HSCS (STOCKS)
HeartSciences Inc. Common Stock
$3.170000
+0.010000 (+0.32%)
Prev close: $3.160000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Andrew Christopher Simpson
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $10.51M
- Employees
- 12
- P/E (TTM)
- -0.46
- P/B (TTM)
- 2.33
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q2)
|
$-0.85 | $-2.01 | +1.1645 | +57.81% |
|
Sep 2025 (Q1)
|
$-1.58 | $-1.94 | +0.3580 | +18.47% |
|
Jun 2025 (Q4)
|
$-1.88 | $-2.30 | +0.4150 | +18.08% |
|
Mar 2025 (Q3)
|
$-2.57 | $-2.42 | -0.1526 | -6.31% |
Financial Statements
| Revenues | $8.67K |
| Nonoperating Income/Loss | -$796.99K |
| Operating Expenses | $8.24M |
| Selling, General, and Administrative Expenses | $4.56M |
| Research and Development | $3.69M |
| Operating Income/Loss | -$8.24M |
| Income/Loss From Continuing Operations After Tax | -$9.04M |
| Income/Loss From Continuing Operations Before Tax | $4.14M |
| Net Income/Loss | -$9.04M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$9.04M |
| Net Income/Loss Available To Common Stockholders, Basic | -$9.04M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$6.88 |
| Diluted Earnings Per Share | -$6.88 |
| Basic Average Shares | 5,114,296 |
| Diluted Average Shares | 5,114,296 |
| Assets | $6.00M |
| Current Assets | $3.79M |
| Inventory | $657.29K |
| Prepaid Expenses | $221.64K |
| Other Current Assets | $2.91M |
| Noncurrent Assets | $2.20M |
| Fixed Assets | $52.99K |
| Other Non-current Assets | $2.15M |
| Liabilities | $1.81M |
| Current Liabilities | $1.57M |
| Accounts Payable | $317.39K |
| Other Current Liabilities | $1.25M |
| Noncurrent Liabilities | $247.26K |
| Equity | $4.18M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $4.18M |
| Liabilities And Equity | $6.00M |
| Net Cash Flow From Operating Activities | -$7.50M |
| Net Cash Flow From Operating Activities, Continuing | -$7.50M |
| Net Cash Flow From Investing Activities | -$40.10K |
| Net Cash Flow From Investing Activities, Continuing | -$40.10K |
| Net Cash Flow From Financing Activities | $5.44M |
| Net Cash Flow From Financing Activities, Continuing | $5.44M |
| Net Cash Flow | -$2.10M |
| Net Cash Flow, Continuing | -$2.10M |
| Comprehensive Income/Loss | -$9.04M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$9.04M |
| Other Comprehensive Income/Loss | $0.00 |